Cero Terapeutics Hldg Inc (CERO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 4,846 | 4,426 | 4,363 | 4,724 | 4,951 |
| Operating Income | -4,846 | -4,426 | -4,363 | -4,724 | -4,951 |
| Interest Expense | 166 | 0 | 0 | -14 | 0 |
| Other Income | -874 | -114 | -494 | -707 | -155 |
| Pre-tax Income | -5,886 | -4,541 | -4,856 | -5,417 | -5,106 |
| Net Income Continuous | -5,886 | -4,541 | -4,856 | -5,417 | -5,106 |
| Net Income | $-5,886 | $-4,541 | $-4,856 | $-5,417 | $-5,106 |
| EPS Basic Total Ops | -0.20 | 80.05 | -9.10 | -61.71 | -31.82 |
| EPS Basic Continuous Ops | -0.20 | 40.02 | -3.84 | -11.10 | -29.79 |
| EPS Diluted Total Ops | -0.20 | 80.05 | -9.10 | -61.71 | -31.82 |
| EPS Diluted Continuous Ops | -0.20 | 40.02 | -3.84 | -11.10 | -29.79 |
| EPS Diluted Before Non-Recurring Items | N/A | N/A | -9.10 | -61.71 | -31.80 |
| EBITDA(a) | $-4,433 | $-4,150 | $-4,090 | $-4,456 | $-4,681 |